Who will Trump announce as next FDA commissioner?
As of Wed, 05 Aug 2026 02:02:00 UTC, Polymarket traders price Kyle Diamantas (0.5%), Grace Graham (0.1%). The market has $2K in volume and closes on Thu, 31 Dec 2026.
Updated:
Current odds
| Outcome | Chance | Yes price | No price |
|---|---|---|---|
| Kyle Diamantas | 0.5% | 0.5¢ | 99.5¢ |
| Grace Graham | 0.1% | 0.1¢ | 100.0¢ |
Market details
- Venue: Polymarket
- Volume: $2K
- Liquidity: $19K
- Closes:
Resolution rules
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.
Sources
Related markets
- Venezuela leader end of 2026?
- Who will be Trump's next Press Secretary?
- Who will leave their role in the Trump administration this year?
- Will Trump buy at least part of Greenland?
- Will marijuana be rescheduled?
- Will the House impeach Trump?
More markets like this
- FDA approves Retatrutide this year?
- FDA approves skin cancer vaccine by...?
- FDA moves BPC-157 to Category 1 by…?
- Heidi Overton confirmed as FDA Commissioner by...?
- Who will Trump endorse first in the 2028 US presidential election?
- Who will Trump meet with by November 30?
- Who will Trump meet with in 2026?
- Who will Trump name as AI czar?
A price on DOXA is the market-implied probability of an outcome on the venue that lists it. It is what traders are paying, not a forecast made by DOXA, and it is not investment advice. How DOXA shows prices · Terms of Use
DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.